Cancer immunotherapy treatment dramatically reduces sunspots – University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also helps reduce sunspots and skin cancers by at least 65 per cent. Over 12 months, researchers monitored 23 patients receiving immunotherapy for unrelated cancers and found the treatment also targeted cancerous and […]
Read More… from Cancer immunotherapy treatment dramatically reduces sunspots
Scientists have developed a new way of using cancers’ DNA to spot cancer patients who may benefit from immunotherapy. Researchers developed a computer algorithm to tell the difference between two different strategies that tumours use to hide from the immune system – one of which is better at dodging the effects of immunotherapy than the […]
Read More… from Immunotherapy: Algorithm spots patients likely to respond
Skin cancer: new immunotherapy treatment strategies improve prognosis – but prevention is still essential: Immunotherapy has revolutionised the treatment of inoperable, metastasised skin cancer. More than 50% of patients are still alive more than five years after treatment, whereas, 10 years ago, this figure was not even 5%. The experts from the Comprehensive Cancer Center […]
Potential marker for success of immunotherapy in the treatment of lung cancer: Lung cancer has the highest mortality rate of all cancers, and treatment options are extremely limited, especially for patients with oncogenic mutations in the KRAS gene. A great deal of hope was invested in the licensing of immune checkpoint inhibitors, but the reality […]
High thrombotic risk in cancer patients receiving immunotherapy: In a study recently published in the leading journal “Blood”, Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the […]
Read More… from High thrombotic risk in cancer patients receiving immunotherapy
Aggressive cancers could be treated with immunotherapies that direct the immune system to kill cancer cells with specific drug resistance-causing mutations, a major new study suggests. Drug resistance mutations which restore activity of the BRCA1 or BRCA2 genes as a way of avoiding the effects of drug treatment could leave tumours vulnerable to the effects […]
Read More… from Immune system could be trained to spot drug-resistant cancers
Immunotherapy pembrolizumab keeps some patients alive for three years or more Pembrolizumab either used alone or in combination with chemotherapy was more effective than a standard cocktail of chemotherapy drugs in a study involving nearly 900 patients. For patients who responded to treatment, the duration of response was five times longer for pembrolizumab alone than […]
Read More… from Immunotherapy Backed as Standard First-line Treatment for Head and Neck Cancer
Immunotherapy, which was first trialled on hay fever patients in London in 1911, has an excellent record in helping reduce allergy symptoms. But how long it works after treatment stops seems to depend of how long patients receive the therapy, which involves increasing exposure to grass pollen over time. This is the conclusion of researchers at […]